27-11-2024 12:05 via drugs.com

Zepbound Slashes Diabetes Risk in Obese Users

WEDNESDAY, Nov. 27, 2024-- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found.Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90%...
Read more »